This corporate profile goes with the post ‘Cool’ technology helps patients but red ink flows.
ALSIUS CORP.
Business: Develops, manufactures and sells computerized systems to regulate critically ill or surgical patients’ body temperature through catheters containing temperature-controlled saline solution.
Headquarters: 15770 Laguna Canyon Road, Irvine
Employees: 100
Ownership: publicly traded company.
Stock exchange: Nasdaq
Ticker: ALUS
Recent share price: $2.50 on Aug. 6
Revenue (2007): $9.1 million
Loss (2007): $22.2 million
Top-selling products: Thermogard XP, CoolGard 3000 and a family of one-time-use catheters (Cool Line, Icy and Quattro) that go with those systems. More than 600 systems have been installed in 330 hospitals worldwide.
History: Founded 1998
More info: 949-453-0150, www.alsius.com
Reader comments: We want this to be a place where people discuss and debate ideas that foster stronger communities. We expect people to differ -- judgment and opinion are subjective -- and we encourage free speech and the exchange of ideas. But you are participating in a community that is intended for all of our users and we prohibit profanity, vulgarity, racial, sexual and homophobic remarks, threats, harassment and personal attacks. Here's the full User Agreement. Thank you for making this a safe place worth preserving and sharing. Share this: The icons below make it easy to share this post with others. First icon e-mails a link.
Posted in: Heart • Surgery • Alsius |
You can follow any responses to this entry through the RSS 2.0 feed.
You can skip to the end and leave a response. Pinging is currently not allowed.
